Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Aimée du Chatinier

Aimée du Chatinier

PhD student

Identification of epigenetic drugs as radiosensitizers and escape mechanisms in pediatric high-grade gliomas

Phone 088 97 25 214
Email A.duChatinier@prinsesmaximacentrum.nl

Publications

11 publications in total

  • Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    • sep. 2024
    • Dennis S., Metselaar, et al
    • Cell Reports Medicine

  • Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    • sep. 2024
    • Dennis S, Metselaar, et al
    • Cell Reports Medicine

  • Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

    • mrt. 2024
    • Annelisa M., Cornel, et al
    • Journal for ImmunoTherapy of Cancer

  • Microglia in pediatric brain tumors

    • nov. 2023
    • Aimée, du Chatinier, et al
    • Cell Reports Medicine

  • Microglia in pediatric brain tumors

    • nov. 2023
    • Aimée, du Chatinier, et al
    • Cell Reports Medicine
View all publications